AIDS TREATMENT NEWS Issue #362, March 23, 2001
John S. James
Major sections include:
* treatments for HIV infection (listed alphabetically within each of three categories, FDA-approved drugs, experimental agents, and immune-based therapies);
* treatments and treatment results for opportunistic infections;
* articles on current issues: "Muscle, Fat, and HIV," "Nucleoside Analog Toxicity," and two articles on treatment in Uganda, and in a separate section, "The Shifting Pattern of Opportunistic Illness";
* actively recruiting clinical trials;
* the U.S. treatment guidelines for adults and adolescents, pediatric guidelines, and guidelines on prevention of opportunistic infections. [The adult guidelines were recently changed, after this edition of the directory had gone to press. So the adult guidelines, pages 91-103 of volume 11 number 1, are not current and should not be used; the current guidelines are available at http://www.hivatis.org or by mail from HIV/AIDS Treatment Information Service, P.O. Box 6303, Rockville, MD 20849- 6303. A new edition of the treatment directory with the current guidelines should be published around June 2001.]
* information on understanding your lab results;
* a directory of state ADAP (AIDS Drug Assistance Program) phone numbers;
* a directory of pharmaceutical company patient assistance programs;
* an index to manufacturers, arranged alphabetically by drug name;
* newsletters and other treatment information resources; and
* the "HIV Experimental Vaccine Directory."
You can obtain a printed copy of the HIV/AIDS TREATMENT DIRECTORY from American Foundation for AIDS Research, 120 Wall St., 13th Floor, New York, NY 10005, phone 212-806- 1600, or email txdir@amfar.org. An online version of the directory is available at http://www.amfar.org/td
010323
ATN36204
Copyright © 2001 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
ÆGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1990, 2000. ÆGIS. All materials appearing on ÆGIS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS, or the party credited as the provider of the content. Feedback/Contact Us.